The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam

<p>Abstract</p> <p>Background</p> <p>In Vietnam, the artemisinin-based combination therapy (ACT) of dihydroartemisinin-piperaquine is currently used for first-line treatment of uncomplicated <it>Plasmodium falciparum</it> malaria. However, limited efficacy a...

Full description

Bibliographic Details
Published in:	Malaria Journal
Main Authors:	Thanh Nguyen, Trung Trieu, Phong Nguyen, Quang Huynh, Dai Bui, Shanks G, Chavchich Marina, Edstein Michael D
Format:	Article
Language:	English
Published:	BMC 2012-06-01
Subjects:	Malaria <it>Plasmodium falciparum</it> Artemisinin Piperaquine Artesunate Amodiaquine
Online Access:	http://www.malariajournal.com/content/11/1/217

Similar Items

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
by: Abel Nhama, et al.
Published: (2025-07-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance
by: Mahamat Souleymane Issa, et al.
Published: (2023-08-01)

Artesunate-amodiaquine fixed dose combination for the treatment of <it>Plasmodium falciparum </it>malaria in India
by: Anvikar Anupkumar R, et al.
Published: (2012-03-01)

Efficacy of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children aged 2–11 years in the Asante Akim North Municipality, Ghana: a single-arm open trial
by: Henry Hanson, et al.
Published: (2025-10-01)

Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar
by: Irinantenaina Judickaëlle, et al.
Published: (2023-01-01)

Meta-Analysis of Data from Four Clinical Trials in the Ivory Coast Assessing the Efficacy of Two Artemisinin-Based Combination Therapies (Artesunate-Amodiaquine and Artemether-Lumefantrine) between 2009 and 2016
by: Akoua Valérie Bédia-Tanoh, et al.
Published: (2023-12-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017
by: Benjamin Abuaku, et al.
Published: (2019-06-01)

Lack of selection of antimalarial drug resistance markers after intermittent preventive treatment of schoolchildren (IPTsc) against malaria in northeastern Tanzania
by: Frederik Von Wowern, et al.
Published: (2024-09-01)

Efficacy of fixed-dose combination artesunate-amodiaquine <it>versus</it> artemether-lumefantrine for uncomplicated childhood <it>Plasmodium falciparum</it> malaria in Democratic Republic of Congo: a randomized non-inferiority trial
by: Espié Emmanuelle, et al.
Published: (2012-05-01)

Early effects of concurrent administration of artesunate-amodiaquine and nifedipine on sperm parameters and sex hormones in guinea pigs: An experimental study
by: Jonah Sydney Aprioku
Published: (2018-10-01)

The Effects of Frequent Therapeutic Administration of Artesunate-amodiaquine and Artemether-lumefantrine on Haematological Markers in BALB/c Mice
by: David Audu, et al.
Published: (2023-03-01)

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
by: Alphonse Ouédraogo, et al.
Published: (2024-12-01)

Xylopic acid-amodiaquine and xylopic acid-artesunate combinations are effective in managing malaria in Plasmodium berghei-infected mice
by: Silas Acheampong Osei, et al.
Published: (2021-02-01)

The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
by: Agnandji Selidji T, et al.
Published: (2011-12-01)

A non-randomized, open-label study to assess the impact of rounds of mass drug administration with artemisinin-piperaquine plus primaquine on malaria in São Tomé Island
by: Mingqiang Li, et al.
Published: (2025-05-01)

Efikasi Obat Kloroquine, Kina, Artesunate-SP, Artesunate-Amodiaquine, Artesunate-Lumafentrin pada Anak Malaria Falciparum di BLU RSUP Prof. Dr. RD. Kandou Manado
by: Suryadi Nicolaas Napoleon Tatura
Published: (2016-11-01)

Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo
by: Brice Pembet Singana, et al.
Published: (2022-05-01)

Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved]
by: Peter Mwitari, et al.
Published: (2023-10-01)

A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands
by: Guoming Li, et al.
Published: (2023-04-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Artemisinin and Its Derivatives as Potential Anticancer Agents
by: Luan Wen, et al.
Published: (2024-08-01)

Post-artesunate delayed haemolysis ‒ report of four cases and review of the literature
by: Olivier Boillat, et al.
Published: (2015-11-01)

Pilot plant production of Anti-malarial Drug piperaquine phosphate and synthesis of its metabolites
by: Nguyen Van Hung, et al.
Published: (2011-12-01)

Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report
by: Jenny Hill, et al.
Published: (2024-03-01)

No evidence of molecular markers of piperaquine resistance in southeastern Nigeria
by: Moses Ikegbunam, et al.
Published: (2025-09-01)

Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children
by: Djimde Abdoulaye A., et al.
Published: (2016-01-01)

LC-MS/TOF Characterization and Stability Study of Artesunate in Different Solvent Systems
by: Kogila Oke, et al.
Published: (2022-08-01)

Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria
by: Dinkorma T. Ouologuem, et al.
Published: (2018-12-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01)

Longitudinal study of Plasmodium pathogens identifies new loci associated with artemisinin resistance
by: Elizabeth A. Winzeler
Published: (2017-04-01)

Genetic surveillance shows spread of ACT resistance during period of malaria decline in Vietnam (2018-2020)
by: Johanna Helena Kattenberg, et al.
Published: (2024-12-01)

Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c)
by: David Audu, et al.
Published: (2023-10-01)

A REVIEW OF CLINICAL STUDIES OF ANTICANCER ACTIVITY OF ARTEMISININ DERIVATIVE
by: D. A. Konovalov, et al.
Published: (2018-11-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)

Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan
by: Tajeldin M Abdallah, et al.
Published: (2014-05-01)

A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II/III to piperaquine drug resistance
by: John Kane, et al.
Published: (2024-07-01)

In vitro assessment of the anti-adenoviral activity of artemisinin and its derivatives
by: Diyuan Yang, et al.
Published: (2024-11-01)

Editorial: Drugs and methods that enhance the anti-cancer efficacy of artesunate
by: Tuğçenur Uzun
Published: (2025-03-01)

From malaria fighter to diabetes guardian: the emerging role of artesunate in treating diabetes and diabetic complications
by: Dongze Li, et al.
Published: (2025-05-01)

Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates
by: Elena Marchesi, et al.
Published: (2023-08-01)